U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Osteogenesis imperfecta type 15(OI15)

MedGen UID:
815174
Concept ID:
C3808844
Disease or Syndrome
Synonyms: OI, TYPE XV; Osteogenesis imperfecta, type xv; WNT1-related osteogenesis imperfecta
 
Gene (location): WNT1 (12q13.12)
 
Monarch Initiative: MONDO:0014086
OMIM®: 615220

Definition

Osteogenesis imperfecta (OI) is a connective tissue disorder characterized by bone fragility and low bone mass. Due to considerable phenotypic variability, Sillence et al. (1979) developed a classification of OI subtypes based on clinical features and disease severity: OI type I, with blue sclerae (166200); perinatal lethal OI type II, also known as congenital OI (166210); OI type III, a progressively deforming form with normal sclerae (259420); and OI type IV, with normal sclerae (166220). Most forms of OI are autosomal dominant with mutations in one of the 2 genes that code for type I collagen alpha chains, COL1A1 (120150) and COL1A2 (120160). Keupp et al. (2013) and Pyott et al. (2013) described osteogenesis imperfecta type XV, an autosomal recessive form of the disorder characterized by early-onset recurrent fractures, bone deformity, significant reduction of bone density, short stature, and, in some patients, blue sclera. Tooth development and hearing are normal. Learning and developmental delays and brain anomalies have been observed in some patients. [from OMIM]

Additional description

From MedlinePlus Genetics
Osteogenesis imperfecta (OI) is a group of genetic disorders that mainly affect the bones. The term "osteogenesis imperfecta" means imperfect bone formation. People with this condition have bones that break (fracture) easily, often from mild trauma or with no apparent cause. Multiple fractures are common, and in severe cases, can occur even before birth. Milder cases may involve only a few fractures over a person's lifetime.

There are at least 19 recognized forms of osteogenesis imperfecta, designated type I through type XIX. Several types are distinguished by their signs and symptoms, although their characteristic features overlap. Increasingly, genetic causes are used to define rarer forms of osteogenesis imperfecta. Type I (also known as classic non-deforming osteogenesis imperfecta with blue sclerae) is the mildest form of osteogenesis imperfecta. Type II (also known as perinatally lethal osteogenesis imperfecta) is the most severe. Other types of this condition, including types III (progressively deforming osteogenesis imperfecta) and IV (common variable osteogenesis imperfecta with normal sclerae), have signs and symptoms that fall somewhere between these two extremes.

The milder forms of osteogenesis imperfecta, including type I, are characterized by bone fractures during childhood and adolescence that often result from minor trauma, such as falling while learning to walk. Fractures occur less frequently in adulthood. People with mild forms of the condition typically have a blue or grey tint to the part of the eye that is usually white (the sclera), and about half develop hearing loss in adulthood. Unlike more severely affected individuals, people with type I are usually of normal or near normal height.

Other types of osteogenesis imperfecta are more severe, causing frequent bone fractures that are present at birth and result from little or no trauma. Additional features of these types can include blue sclerae of the eyes, short stature, curvature of the spine (scoliosis), joint deformities (contractures), hearing loss, respiratory problems, and a disorder of tooth development called dentinogenesis imperfecta. Mobility can be reduced in affected individuals, and some may use a walker or wheelchair. The most severe forms of osteogenesis imperfecta, particularly type II, can include an abnormally small, fragile rib cage and underdeveloped lungs. Infants with these abnormalities may have life-threatening problems with breathing and can die shortly after birth.  https://medlineplus.gov/genetics/condition/osteogenesis-imperfecta

Clinical features

From HPO
Short stature
MedGen UID:
87607
Concept ID:
C0349588
Finding
A height below that which is expected according to age and gender norms. Although there is no universally accepted definition of short stature, many refer to "short stature" as height more than 2 standard deviations below the mean for age and gender (or below the 3rd percentile for age and gender dependent norms).
Cerebellar hypoplasia
MedGen UID:
120578
Concept ID:
C0266470
Congenital Abnormality
Cerebellar hypoplasia is a descriptive term implying a cerebellum with a reduced volume, but a normal shape and is stable over time.
Schizencephaly
MedGen UID:
78606
Concept ID:
C0266484
Congenital Abnormality
Brunelli et al. (1996) described schizencephaly as an extremely rare congenital disorder characterized by a full-thickness cleft within the cerebral hemispheres. The clefts are lined with gray matter and most commonly involve the parasylvian regions (Wolpert and Barnes, 1992). Large portions of the cerebral hemispheres may be absent and replaced by cerebrospinal fluid. Two types of schizencephaly have been described, depending on the size of the area involved and the separation of the cleft lips (Wolpert and Barnes, 1992). Type I schizencephaly consists of a fused cleft. This fused pial-ependymal seam forms a furrow in the developing brain, and is lined by polymicrogyric gray matter. In type II schizencephaly, there is a large defect, a holohemispheric cleft in the cerebral cortex filled with fluid and lined by polymicrogyric gray matter. The clinical manifestations depend on the severity of the lesion. Patients with type I are often almost normal; they may have seizures and spasticity. In type II abnormalities, there is usually mental retardation, seizures, hypotonia, spasticity, inability to walk or speak, and blindness. Schizencephaly may be part of the larger phenotypic spectrum of holoprosencephaly (HPE; see 236100).
Global developmental delay
MedGen UID:
107838
Concept ID:
C0557874
Finding
A delay in the achievement of motor or mental milestones in the domains of development of a child, including motor skills, speech and language, cognitive skills, and social and emotional skills. This term should only be used to describe children younger than five years of age.
Hypoplasia of the pons
MedGen UID:
341246
Concept ID:
C1848529
Finding
Underdevelopment of the pons.
Recurrent fractures
MedGen UID:
42094
Concept ID:
C0016655
Injury or Poisoning
The repeated occurrence of bone fractures (implying an abnormally increased tendency for fracture).
Scoliosis
MedGen UID:
11348
Concept ID:
C0036439
Disease or Syndrome
The presence of an abnormal lateral curvature of the spine.
Thin ribs
MedGen UID:
98095
Concept ID:
C0426818
Finding
Ribs with a reduced diameter.
Platyspondyly
MedGen UID:
335010
Concept ID:
C1844704
Finding
A flattened vertebral body shape with reduced distance between the vertebral endplates.
Joint hypermobility
MedGen UID:
336793
Concept ID:
C1844820
Finding
The capability that a joint (or a group of joints) has to move, passively and/or actively, beyond normal limits along physiological axes.
Bowing of limbs due to multiple fractures
MedGen UID:
376722
Concept ID:
C1850178
Finding
Curvature of the shafts of the long bones due to multiple fractures.
Blue sclerae
MedGen UID:
154236
Concept ID:
C0542514
Finding
An abnormal bluish coloration of the sclera.

Professional guidelines

PubMed

Lin X, Hu J, Zhou B, Zhang Q, Jiang Y, Wang O, Xia W, Xing X, Li M
J Endocrinol Invest 2024 Jan;47(1):67-77. Epub 2023 Jun 4 doi: 10.1007/s40618-023-02123-2. PMID: 37270749Free PMC Article
Thompson EM
Am J Med Genet 1993 Jan 15;45(2):201-6. doi: 10.1002/ajmg.1320450210. PMID: 8456803
Constantine G, McCormack J, McHugo J, Fowlie A
Prenat Diagn 1991 Feb;11(2):103-10. doi: 10.1002/pd.1970110205. PMID: 2062815

Recent clinical studies

Etiology

Botor M, Fus-Kujawa A, Uroczynska M, Stepien KL, Galicka A, Gawron K, Sieron AL
Biomolecules 2021 Oct 10;11(10) doi: 10.3390/biom11101493. PMID: 34680126Free PMC Article
Taqi D, Moussa H, Schwinghamer T, Vieira AR, Dagdeviren D, Retrouvey JM, Rauch F, Tamimi F; Members of the BBDC
Bone 2021 Sep;150:116011. Epub 2021 May 18 doi: 10.1016/j.bone.2021.116011. PMID: 34020077
Waissbluth S, Lira K, Aracena K, Oyarzun J, Willson M, Seiltgens C
Rev Med Chil 2020 Dec;148(12):1781-1786. doi: 10.4067/S0034-98872020001201781. PMID: 33844744
Díaz López M, Alegre Sancho JJ, Martínez-Ferrer À
Reumatol Clin (Engl Ed) 2020 Mar-Apr;16(2 Pt 2):165-168. Epub 2018 Jul 17 doi: 10.1016/j.reuma.2018.05.004. PMID: 30017614
Bronheim R, Khan S, Carter E, Sandhaus RA, Raggio C
Spine (Phila Pa 1976) 2019 Aug 1;44(15):1057-1063. doi: 10.1097/BRS.0000000000003012. PMID: 31335789

Diagnosis

Lin X, Hu J, Zhou B, Zhang Q, Jiang Y, Wang O, Xia W, Xing X, Li M
J Endocrinol Invest 2024 Jan;47(1):67-77. Epub 2023 Jun 4 doi: 10.1007/s40618-023-02123-2. PMID: 37270749Free PMC Article
Venable E, Knight DRT, Thoreson EK, Baudhuin LM
Am J Med Genet C Semin Med Genet 2023 Jun;193(2):147-159. Epub 2023 Mar 9 doi: 10.1002/ajmg.c.32038. PMID: 36896471
Waissbluth S, Lira K, Aracena K, Oyarzun J, Willson M, Seiltgens C
Rev Med Chil 2020 Dec;148(12):1781-1786. doi: 10.4067/S0034-98872020001201781. PMID: 33844744
Díaz López M, Alegre Sancho JJ, Martínez-Ferrer À
Reumatol Clin (Engl Ed) 2020 Mar-Apr;16(2 Pt 2):165-168. Epub 2018 Jul 17 doi: 10.1016/j.reuma.2018.05.004. PMID: 30017614
Cohen MM Jr
Am J Med Genet Suppl 1988;4:99-148. doi: 10.1002/ajmg.1320310514. PMID: 3144990

Therapy

Zheng WB, Hu J, Zhang J, Yang Z, Wang O, Jiang Y, Xia WB, Xing XP, Yu W, Li M
Calcif Tissue Int 2022 Apr;110(4):451-463. Epub 2022 Jan 6 doi: 10.1007/s00223-021-00932-2. PMID: 34988594
Pantoja LLQ, Lustosa M, Yamaguti PM, Rosa LS, Leite AF, Figueiredo PTS, Castro LC, Acevedo AC
Calcif Tissue Int 2022 Mar;110(3):303-312. Epub 2021 Oct 22 doi: 10.1007/s00223-021-00915-3. PMID: 34677656
Lee CL, Liu SC, Yang CY, Chuang CK, Lin HY, Lin SP
Int J Med Sci 2021;18(5):1240-1246. Epub 2021 Jan 14 doi: 10.7150/ijms.53286. PMID: 33526985Free PMC Article
Peddada KV, Sullivan BT, Margalit A, Sponseller PD
J Pediatr Orthop 2018 Apr;38(4):e207-e212. doi: 10.1097/BPO.0000000000001137. PMID: 29356793
Fiegel MJ
Semin Cardiothorac Vasc Anesth 2011 Sep;15(3):98-101. Epub 2011 Aug 2 doi: 10.1177/1089253211412978. PMID: 21813546

Prognosis

Lin X, Hu J, Zhou B, Zhang Q, Jiang Y, Wang O, Xia W, Xing X, Li M
J Endocrinol Invest 2024 Jan;47(1):67-77. Epub 2023 Jun 4 doi: 10.1007/s40618-023-02123-2. PMID: 37270749Free PMC Article
Li D, Ou M, Dai G, Zhu P, Luo Q, Chen J, Shah Z, Samokhvalov IM, Yin L, Sun G, Tang D, Dai Y
Front Biosci (Landmark Ed) 2023 Dec 12;28(12):336. doi: 10.31083/j.fbl2812336. PMID: 38179771
Lee CL, Liu SC, Yang CY, Chuang CK, Lin HY, Lin SP
Int J Med Sci 2021;18(5):1240-1246. Epub 2021 Jan 14 doi: 10.7150/ijms.53286. PMID: 33526985Free PMC Article
Bronheim R, Khan S, Carter E, Sandhaus RA, Raggio C
Spine (Phila Pa 1976) 2019 Aug 1;44(15):1057-1063. doi: 10.1097/BRS.0000000000003012. PMID: 31335789
Fiegel MJ
Semin Cardiothorac Vasc Anesth 2011 Sep;15(3):98-101. Epub 2011 Aug 2 doi: 10.1177/1089253211412978. PMID: 21813546

Clinical prediction guides

Lin X, Hu J, Zhou B, Zhang Q, Jiang Y, Wang O, Xia W, Xing X, Li M
J Endocrinol Invest 2024 Jan;47(1):67-77. Epub 2023 Jun 4 doi: 10.1007/s40618-023-02123-2. PMID: 37270749Free PMC Article
Venable E, Knight DRT, Thoreson EK, Baudhuin LM
Am J Med Genet C Semin Med Genet 2023 Jun;193(2):147-159. Epub 2023 Mar 9 doi: 10.1002/ajmg.c.32038. PMID: 36896471
Waissbluth S, Lira K, Aracena K, Oyarzun J, Willson M, Seiltgens C
Rev Med Chil 2020 Dec;148(12):1781-1786. doi: 10.4067/S0034-98872020001201781. PMID: 33844744
Bronheim R, Khan S, Carter E, Sandhaus RA, Raggio C
Spine (Phila Pa 1976) 2019 Aug 1;44(15):1057-1063. doi: 10.1097/BRS.0000000000003012. PMID: 31335789
Van Dijk FS, Pals G, Van Rijn RR, Nikkels PG, Cobben JM
Eur J Med Genet 2010 Jan-Feb;53(1):1-5. Epub 2009 Oct 28 doi: 10.1016/j.ejmg.2009.10.007. PMID: 19878741

Recent systematic reviews

Brunetti G, D'Amato G, Chiarito M, Tullo A, Colaianni G, Colucci S, Grano M, Faienza MF
World J Pediatr 2019 Feb;15(1):4-11. Epub 2018 Oct 20 doi: 10.1007/s12519-018-0198-7. PMID: 30343446
Beecham E, Candy B, Howard R, McCulloch R, Laddie J, Rees H, Vickerstaff V, Bluebond-Langner M, Jones L
Cochrane Database Syst Rev 2015 Mar 13;2015(3):CD010750. doi: 10.1002/14651858.CD010750.pub2. PMID: 25768935Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...